SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-20-003225
Filing Date
2020-05-28
Accepted
2020-05-28 06:08:22
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B5 a2241714z424b5.htm 424B5 290763
2 G936442.JPG g936442.jpg GRAPHIC 19417
3 G541111.JPG g541111.jpg GRAPHIC 91661
4 G429354.JPG g429354.jpg GRAPHIC 97794
5 G732609.JPG g732609.jpg GRAPHIC 83680
6 G658271.JPG g658271.jpg GRAPHIC 27211
7 G717743.JPG g717743.jpg GRAPHIC 36281
  Complete submission text file 0001047469-20-003225.txt   783017
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-238140 | Film No.: 20916848
SIC: 2834 Pharmaceutical Preparations